Tariq Patel

All read papers (43)

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

Maude SL, Laetsch TW, Buechner J, Rives S, Boyer M, Bittencourt H, Bader P, Verneris MR, Stefanski HE, Myers GD, Qayed M, De Moerloose B, Hiramatsu H, Schlis K, Davis KL, Martin PL, Nemecek ER, Yanik GA, Peters C, Baruchel A, Boissel N, Mechinaud F, Balduzzi A, Krueger J, June CH, Levine BL, Wood P, Taran T, Leung M, Mueller KT, Zhang Y, Sen K, Lebwohl D, Pulsipher MA, Grupp SA.

N Engl J Med · 2018

2.0/5

Understanding the tumor immune microenvironment (TIME) for effective therapy

Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, Vonderheide RH, Pittet MJ, Jain RK, Zou W, Howcroft TK, Woodhouse EC, Weinberg RA, Krummel MF.

Nat Med · 2018

2.8/5

TREM2 variants in Alzheimer's disease

Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J, Alzheimer Genetic Analysis Group.

N Engl J Med · 2013

3.5/5

Pfam: The protein families database in 2021

Mistry J, Chuguransky S, Williams L, Qureshi M, Salazar GA, Sonnhammer ELL, Tosatto SCE, Paladin L, Raj S, Richardson LJ, Finn RD, Bateman A.

Nucleic Acids Res · 2021

2.0/5

Alzheimer's disease is a synaptic failure

Selkoe DJ.

Science · 2002

3.0/5

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, Gordon MS, Sosman JA, McDermott DF, Powderly JD, Gettinger SN, Kohrt HE, Horn L, Lawrence DP, Rost S, Leabman M, Xiao Y, Mokatrin A, Koeppen H, Hegde PS, Mellman I, Chen DS, Hodi FS.

Nature · 2014

3.0/5

mTOR Signaling in Growth, Metabolism, and Disease

Saxton RA, Sabatini DM.

Cell · 2017

4.0/5

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses.

Nat Microbiol · 2020

3.8/5

DADA2: High-resolution sample inference from Illumina amplicon data

Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP.

Nat Methods · 2016

2.5/5

Long COVID: major findings, mechanisms and recommendations

Davis HE, McCorkell L, Vogel JM, Topol EJ.

Nat Rev Microbiol · 2023

3.8/5

Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing

Cheng Q, Wei T, Farbiak L, Johnson LT, Dilliard SA, Siegwart DJ.

Nat Nanotechnol · 2020

1.5/5

Efficient genome editing in zebrafish using a CRISPR-Cas system

Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JR, Joung JK.

Nat Biotechnol · 2013

4.5/5

The amyloid hypothesis of Alzheimer's disease at 25 years

Selkoe DJ, Hardy J.

EMBO Mol Med · 2016

3.3/5

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Gräf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, METABRIC Group, Langerød A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Børresen-Dale AL, Brenton JD, Tavaré S, Caldas C, Aparicio S.

Nature · 2012

3.5/5

Alzheimer's disease

Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM.

Lancet · 2021

3.0/5

The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions

Oughtred R, Rust J, Chang C, Breitkreutz BJ, Stark C, Willems A, Boucher L, Leung G, Kolas N, Zhang F, Dolma S, Coulombe-Huntington J, Chatr-Aryamontri A, Dolinski K, Tyers M.

Protein Sci · 2021

3.0/5

Inferring tumour purity and stromal and immune cell admixture from expression data

Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW, Levine DA, Carter SL, Getz G, Stemke-Hale K, Mills GB, Verhaak RG.

Nat Commun · 2013

3.3/5

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ, ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis.

Am J Respir Crit Care Med · 2011

2.8/5

The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis

Yamamoto M, Kensler TW, Motohashi H.

Physiol Rev · 2018

3.0/5

Generation of functional human pancreatic β cells in vitro

Pagliuca FW, Millman JR, Gürtler M, Segel M, Van Dervort A, Ryu JH, Peterson QP, Greiner D, Melton DA.

Cell · 2014

2.8/5

The Cancer Genome Atlas Pan-Cancer analysis project

Cancer Genome Atlas Research Network, Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM.

Nat Genet · 2013

3.5/5

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A.

Cell · 2017

3.0/5

The Immune Landscape of Cancer

Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS, Cancer Genome Atlas Research Network, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I.

Immunity · 2018

2.5/5

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z.

JAMA · 2020

1.8/5

Full-length transcriptome assembly from RNA-Seq data without a reference genome

Grabherr MG, Haas BJ, Yassour M, Levin JZ, Thompson DA, Amit I, Adiconis X, Fan L, Raychowdhury R, Zeng Q, Chen Z, Mauceli E, Hacohen N, Gnirke A, Rhind N, di Palma F, Birren BW, Nusbaum C, Lindblad-Toh K, Friedman N, Regev A.

Nat Biotechnol · 2011

2.8/5

IL-6 in inflammation, immunity, and disease

Tanaka T, Narazaki M, Kishimoto T.

Cold Spring Harb Perspect Biol · 2014

3.8/5

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM.

Neuron · 2003

2.3/5

Mapping the structural core of human cerebral cortex

Hagmann P, Cammoun L, Gigandet X, Meuli R, Honey CJ, Wedeen VJ, Sporns O.

PLoS Biol · 2008

2.3/5

GSVA: gene set variation analysis for microarray and RNA-seq data

Hänzelmann S, Castelo R, Guinney J.

BMC Bioinformatics · 2013

2.0/5

The neuropathological diagnosis of Alzheimer's disease

DeTure MA, Dickson DW.

Mol Neurodegener · 2019

3.3/5

A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae

Sikorski RS, Hieter P.

Genetics · 1989

2.3/5

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG.

Science · 2003

3.8/5

Immune checkpoint blockade: a common denominator approach to cancer therapy

Topalian SL, Drake CG, Pardoll DM.

Cancer Cell · 2015

3.0/5

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, West AN, Carmona M, Kivork C, Seja E, Cherry G, Gutierrez AJ, Grogan TR, Mateus C, Tomasic G, Glaspy JA, Emerson RO, Robins H, Pierce RH, Elashoff DA, Robert C, Ribas A.

Nature · 2014

2.5/5

CRISPR-Cas systems for editing, regulating and targeting genomes

Sander JD, Joung JK.

Nat Biotechnol · 2014

2.3/5

Loop-mediated isothermal amplification of DNA

Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T.

Nucleic Acids Res · 2000

3.3/5

Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage

Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR.

Nature · 2017

2.5/5

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R.

Cell · 2013

3.5/5

A core gut microbiome in obese and lean twins

Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI.

Nature · 2009

3.0/5

Neuropathological stageing of Alzheimer-related changes

Braak H, Braak E.

Acta Neuropathol · 1991

3.3/5

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Ilyas SI, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ.

Nat Rev Gastroenterol Hepatol · 2020

2.5/5

Metagenomic biomarker discovery and explanation

Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C.

Genome Biol · 2011

2.3/5

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

Öhlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, Corbo V, Oni TE, Hearn SA, Lee EJ, Chio II, Hwang CI, Tiriac H, Baker LA, Engle DD, Feig C, Kultti A, Egeblad M, Fearon DT, Crawford JM, Clevers H, Park Y, Tuveson DA.

J Exp Med · 2017

2.3/5